It was an exciting day of finals at the Raiders Belconnen fields on Saturday, with the semi finals and grand finals of the 2012 ACT Super League series. Please see below for the results. Eagles Win Men’s Super League TitleThe Woden Eagles have claimed the ACT Men’s Super League title, defeating last year’s winners the Northern Phoenix by one touchdown. The Eagles led for the majority of the game and after leading by one touchdown at half-time were able to hold on to claim the title 8-7. Vikings Claim Women’s Super League VictoryThe Tuggeranong Vikings have come from behind to claim the 2012 ACT Super League Women’s Open title, defeating the Canberra City Bears 8-5. The Vikings trailed at half-time by one touchdown but five second half touchdowns to one saw them take away the win by three touchdowns. To see the full match reports, please visit www.acttouch.com.au. Highlights from the Super League finals have been uploaded to the TFA YouTube channel – www.youtube.com/touchfootballaus Related LinksSuper League Finals
“All you have to do – is start.”That’s the message from Australian Men’s Open Touch Football captain, Steve Roberts, in the NRL Touch Football ‘Play our Game’ television commercial, which will be broadcast nationally on Channel Nine and Fox Sports from Sunday, 10 August 2014 and over the coming months. The theme of the 30-second commercial is ‘belief’ with Roberts relaying at his home Touch Football venue at Canterbury-Bankstown and holding a photo of himself from his junior days: “you don’t just become a great footy player overnight; but the more you play, the more you believe in yourself.” The commercial is the third in the series developed by the NRL and broadcast earlier in the year to boost participation and registrations into Rugby League and Touch Football competitions across the country. The previous ads featured NRL stars Jarryd Hayne and Jared Waerea-Hargraves outlining their motivations and backgrounds as kids joining their mates playing in junior rugby league teams as the start of their careers. The Touch Football execution developed through the alliance with the NRL features a cross-section of participants and according to TFA CEO, Colm Maguire, demonstrate their own belief and the diverse nature of the sport: with girls and boys, women and men and a junior mixed team from Touch Football affiliates including the Manly Sea Eagles, Balmain Tigers, Bankstown Jets and Hills Hornets. “We are very excited by the national release of the Touch Football commercial; shining a light on our sport across the lounge-rooms of Australia and encouraging kids and adults of all ages and sizes to play our great game over Summer in coming months,” he said. “As Steve so clearly states and others illustrate in the ad – all people literally have to do is ‘start’ and they’re away; into a lifetime of team bonding, fun, fitness and sharing great times and stories with teammates and opponents alike on and off the footy field.“We are hoping for this to be our biggest season on record with our new NRL Touch Football product brand, new alignment and approaches with our counterparts at the NRL and improved player experiences out on the park proposed now and into the future.” The commercial will be broadcast from 8 August and will run through September and October to promote recruitment and registrations into local competitions for the upcoming Touch Football summer season.A distinct call-to-action element features at the tail-end of the commercial encouraging prospective players to ‘Play our Game’ and visit the playnrl.com/Touch Football website. It’s as easy as keying in their postcode to locate their nearest competition details and registration and contact information to get involved and start playing. The National Rugby League and Touch Football Australia have launched an historic sporting partnership representing the biggest boost to participation and game development in the history of either sport. The two sports (Touch Football and Rugby League) are working together to create under the NRL banner the largest sporting community in the country (over 1 million participants) which will reflect the wider support that exists for Rugby League and the game’s commitment to ensuring there is a ‘place on the field’ for everyone. For all Touch Football news and information go to the TFA website at www.touchfootball.com.au or you can follow us on Facebook (www.facebook.com/touchfootballaustralia) and Twitter (www.twitter.com/touchfootyaus) as well as YouTube (www.youtube.com/touchfootballaus) to see the latest posts and in the lead-up/countdown to new season competitions.Related Files140808_nrl_tf_tvc__play_our_game__media_release_v1_0-pdfRelated LinksNRL TV Commercial
Source:https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624904.htm Reviewed by James Ives, M.Psych. (Editor)Nov 2 2018The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage. Roche Diagnostics issued a voluntary recall of certain test strip lots used with its CoaguChek test meter devices. The recall involves more than 1.1 million packages of CoaguChek XS PT Test Strips that were distributed nationwide from Jan. 12, 2018 to Oct. 29, 2018. Today, the FDA announced this action as a Class I recall, the most serious type of recall, which means use of these devices may cause serious injuries or death.The FDA is warning patients and health care professionals that they should not rely on these test meter devices to monitor warfarin levels if they’re using test strips affected by the recall. Instead, they should have blood drawn from a vein and have their levels measured by a laboratory test or use an alternative meter device.”These strips are widely used and we are working diligently to warn health care providers and the public about the dangers associated with this recall. Using faulty strips can lead to serious errors in medication dosage that could cause serious harm or death in some patients,” said Jeffrey Shuren, M.D., director of the FDA’s Center for Devices and Radiological Health. “We are also working with the company on the swift removal of the recalled strips and to ensure the new corrected strips are distributed to patients and health care providers as quickly as possible.”Millions of Americans take the blood thinner warfarin (also known by the brand names Coumadin and Jantoven) to prevent and treat blood clots. The drug may be prescribed for patients with certain types of irregular heartbeats, blood clots in the legs or lungs, or certain medical device implants such as artificial heart valves. Achieving the correct warfarin dosage is crucial, and patients need regular monitoring to test how long it takes their blood to clot. The response is measured by a blood test to check the International Normalized Ratio, or INR. This test can be performed by an accredited laboratory on blood drawn from a vein or with a fingerstick blood draw using an INR test meter at home or in a doctor’s office.The FDA’s warning concerning the CoaguChek XS PT Test Strips is based on medical device reports submitted by Roche Diagnostics to the agency indicating that the test strips may provide results that are higher than the actual INR. As a result of incorrect INR results, some patients may be prescribed an insufficient warfarin dose or instructed to interrupt warfarin use, which may increase the risk for dangerous blood clots. Approximately 90 medical device reports and two serious patient injuries involving strokes were reported to the FDA.Related StoriesScientists turn type A blood into universal type O, potentially doubling blood transfusion stocksBlood stem cell breakthrough could spare some patients from side effects of cancer treatmentsRadiometer’s ABL9 blood gas analyzer awarded Red Dot Design AwardIncorrect INR results are of particular concern for individuals at an increased risk of blood clots including those with mechanical heart valves, atrial fibrillation (irregular heartbeat) who are at a high risk of stroke, or those who had a recent blood clot. It is important to note that problems with the CoaguChek XS PT test strips are not likely to be evident to the patient.Roche Diagnostics attributes the cause of the problem to a recent re-calibration of the test strips to a different international standard that occurred earlier this year. They plan to provide new batches of re-calibrated test strips, based on the previous international standard, to their customers by the end of November; the FDA reviewed validation data submitted by the company for these recalibrated strips. The test strips are used with the CoaguChek XS plus, CoaguChek XS Pro, CoaguChek XS professional, CoaguChek XS PST and CoaguChek Vantus test meter devices.Patients who are using CoaguChek meters should contact their health care provider to get information about alternative test methods and to address questions regarding their individual testing schedule. Patients should also contact their patient self-testing service providers to find out when they will be getting their corrected test strips. Health care providers and patients may contact Roche Diagnostics to learn more details about the recall.All health care providers, patients and caregivers, are strongly encouraged to voluntarily report INR test meter problems directly to the FDA through MedWatch, the FDA’s voluntary reporting program. Problems should be reported whenever one suspects that there may be an issue with an INR test meter such as a malfunction or incorrect result, or that the meter caused or contributed to a serious injury or death.The FDA is committed to continuing to communicate publicly on this issue and will provide updates related to this recall when available.
Further Reading Image Credit: Zahraa Saleh / Shutterstock Intranasal vasopressin improves social deficits in children with autismThe first study was conducted on children with autism. Karen Parker, a behavioural scientist at Stanford University, explains that the study of the effects hormone on lab voles was one of her earlier research work. Now she works as the director of the university’s Social Neurosciences Research Program and recruited human children with autism for the study. The study results appeared in the latest issue of the journal Science Translational Medicine this week (1st May 2019). The study was titled, “A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism”.The team writes that they examined the vasopressin levels in the children with autism spectrum disorder. They noted that these children have less amount of vasopressin in their spinal fluid compared to children who were not on the spectrum. They also noted that the symptom severity rose with lower levels of vasopressin. This included severe language and speech difficulties and increase sensitivity, poor IQ and cognitive skills etc.As a next step, Parker and her colleagues conducted a double blinded randomized controlled trial including 30 children with ASD aged between 6 and 12 years. The children were given a nasal spray containing either vasopressin (17 children) or placebo (13 children) over a period of four weeks.Results revealed that children with ASD who were given vasopressin nasal spray had significantly improved social skills and had little or no side effects due to the drug. They noted that the children improved on social communication and also improved on assessment of facial emotions of other people. They could better guess the thinking and feelings of other people. Parents as well as doctors assessing the children reported these improvements. “The parents saw improvement, the clinicians saw improvement, and the children’s performance on lab tests also improved with vasopressin compared to placebo,” Parker said. What is Autism? Autism Causes Autism Mechanism Autism Classification Autism Screening Autism Management Cognitive Behavioral Therapy for Autism The Reward System and Autism Autism and Junk DNA Picky Eating and Autism: Tips & Advice By Dr. Ananya Mandal, MDMay 2 2019Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.Researchers explain the vasopressin is an important hormone in the body that helps to maintain and regulate the kidney functions and blood pressure. Animal studies in the labs revealed that vasopressin has more complex actions in the brains. The hormone can affect social behaviours of the lab animals as well as their bonding with their mates, the researchers noted. There are studies showing the effects of administering vasopressin in healthy humans as well as in humans with dementia and other cognitive problems. The hormone when administered leads to improvement in memory and social skills of the humans, researchers have found. Antonio Hardan, professor of psychiatry and behavioral sciences at Stanford University and co-author of the study said, “Autism is a very heterogeneous disorder. It may be possible, with autism, to see abnormalities that relate to either too much vasopressin or too little.”Parker in one of her statements said, “This is a pilot trial, so it’s important to acknowledge that. But there were significant improvements in kids on vasopressin. And we saw this convergent evidence on parent ratings, clinician evaluations, and laboratory tests of children’s performance.” She added that large trials with more number of children are necessary to prove the efficacy of the hormonal nasal spray in showing improvement. She explained that in her trial there were only 5 girls on ASD since boys were more commonly diagnosed with ASD than girls. She said that larger trials with equal gender representation may be needed to see if there was any gender specific efficacy of the drug.Vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorderResearchers at Roche a Swiss-based pharmaceutical company also conducted a double-blinded, randomized, and controlled trial among adult men on the autism spectrum. The study results appeared in the latest issue of the journal Science Translational Medicine this week (1st May 2019). Senior researcher Dr. Paulo Fontoura senior vice president of neuroscience and rare diseases clinical development at Roche Pharmaceuticals led the study titled, “A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.”For their study the team administered an experimental drug balovaptan or placebo to 223 men with autism. Various doses of the experimental drug was administered (1.5, 4 or 10 milligrams of balovaptan). The mechanism by which the drug acts is by blocking one type of cell receptors in the brain that connects with vasopressin. Fontoura said in a statement that balovaptan has the potential “to improve the core characteristics of social interaction and communications in adults with ASD.” The drug therapy was administered for 12 weeks. Social skills and behaviour in this study as well was measured using the Social Responsiveness Scale.The results of the study showed that there was no significant improvement in the social skills of the men with the drug compared to placebo. The assessment of improvement was made by the primary care givers of the patients. One set of assessment questionnaires were given to patients directly to assess their perception of improvement in the social skills. Results revealed that self-reported benefits in social skills and communication was noted with second-highest and highest doses of the experimental drug.Expert speakThese two sets of researchers had not collaborated on their studies and the studies were independent. Experts have suggested that although one of the trials did not show an outright success, there is a possibility in exploring vasopressin in autism. As a next step, Parker and her team is working on recruiting a large group of children (100 children) on the spectrum to assess the efficacy and safety of their nasal spray. Similarly Roche is also planning a second set of trials with children on the spectrum aged 5 to 17 years. One of the studies is a Phase II trial among children and adolescents while the other phase III trial is among adults.Dr. Andrew Adesman, chief of developmental and behavioural pediatrics at Cohen Children’s Medical Center in New Hyde Park, was sceptical about the efficacy of vasopressin in autism. He said in a statement, “These two studies, taken together, suggest that treatments to increase vasopressin levels in the brain may be helpful for some patients with ASD. However, much more research is needed in terms of the long-term benefits and safety of this type of treatment.” He warned that vasopressin is approved as an antidiuretic to be prescribed by a physician. The hype caused by these studies may tempt patients to use the medication for autism. He said, “I think families and physicians need to be cautious in using this medication on the basis of a single short-term study.” “Given that there are very few if any good medication options for the treatment of ASD, I am sure there will be great interest in this novel treatment approach. That said, I think much more research is needed before we can feel comfortable recommending vasopressin as a safe and effective treatment for one of the core deficits in children with ASD,” he said.Kevin Pelphrey, an autism researcher at the University of Virginia in Charlottesville, spoke about the conflicting results saying, “I’ve never seen this before.” He called the results exciting though adding that the role of vasopressin in the brain is to be studied with renewed interest.Angela Sirigu, neuroscientist at CNRS, in Bron France, is also investigating neurohormones for the management of autism. She called the results exciting.Eric Hollander, professor of psychiatry and behavioral sciences at Albert Einstein College of Medicine in New York, in his statement regarding the studies aid, “These two studies provide important information that the vasopressin or vasopressin and oxytocin systems are important in social communication. Different agents affecting these systems may ultimately be helpful in terms of new treatments for autism.”Lawrence Scahill, director of clinical trials at the Marcus Autism Center in Atlanta also warned about misinterpreting the results of these studies. He said, “Both of these studies suggest that the mechanism is worth further study. But I think we want to be careful not to overinterpret the findings.”Elizabeth Hammock, assistant professor of psychology and neuroscience at Florida State University in Tallahasse added that both the studies looked at two approaches of using vasopressin. She said, “They’re really divergent approaches to targeting the vasopressin system. And we don’t know for sure how either is working.”
Credit: CC0 Public Domain Q&A: How is a bitcoin mined? A look at the virtual currency This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Citation: Bitcoin and cryptocurrency for n00bs (2018, January 8) retrieved 18 July 2019 from https://phys.org/news/2018-01-bitcoin-cryptocurrency-n00bs.html Everyone is talking about it, but no one actually understands it. Read this and impress your friends by explaining bitcoin. Explore further This article first appeared on Particle, a science news website based at Scitech, Perth, Australia. Read the original article. Provided by Particle In a restaurant the other night, I overheard an older couple talking about how their son had made a whole bunch of money with this “new fake online currency”.They were, of course, talking about bitcoin. Bitcoin is indeed an online currency, but it is very far from fake. At the time of writing, one bitcoin was worth over AU$20,000.Bitcoin and blockchain (the technology behind it) was also the subject of a full-day event as part of the recent West Tech Fest in Perth.The reason technology folk are all excited about bitcoin is that it is seen as a way to privately and securely exchange currency through the internet (although, like every technology, bitcoin is not perfect, and researchers are already finding holes).Cryptocurrency?Bitcoin is a form of cryptocurrency, which basically means it’s a type of money or medium of exchange that uses cryptography to ensure the security of transactions.While there are now many different types (you may have also heard of Ethereum), bitcoin was the first and is still the most well known type of cryptocurrency.What bitcoin isn’tThe most obvious entry point to understanding bitcoin is to first start with why bitcoin is different. Or in other words, what bitcoin isn’t.Bitcoin isn’t like conventional currency in four key ways. First, it isn’t issued by the government. Second, it doesn’t have any physical instrument. Bitcoin is entirely digital and only exists online. Third, it doesn’t require a bank.And fourth—and perhaps the most important difference between bitcoin and conventional currency—is the ledger. Ah, and what’s a ledger you ask? Think about your bank statement—it’s a type of ledger. On it, you see a list of transactions—the money going into and out of your account. The bank controls the ledger, and only you and the bank are able to see those transactions.In the case of bitcoin, the ledger is public, and because it is distributed, it is controlled by no one. But while the ledger is public, the entries are anonymised. Perth-based Ian Love, CEO of Australia’s first digital asset management company, Blockchain Assets, describes this as “transparency with anonymity”.Bitcoin mining for fun and profitAnother term you may have heard is ‘bitcoin mining’, which is another way of obtaining bitcoin rather than purchasing it with regular money.To understand how mining works, we again need to think about the distributed nature of bitcoin’s ledger.Another way of getting your head around a distributed ledger is by thinking about the internet itself, which was designed as a decentralised, distributed network of computers that no one person or group controls. (This, unfortunately, is under threat as net neutrality laws are being dismantled in the US, but that’s a story for another day.)The work of maintaining bitcoin still needs to be done, but since no one person or group (like a bank) controls it, the work is distributed. This is what bitcoin mining is—it’s adding transactions to the ledger or the blockchain. Anyone can do it with their computer, and you’re rewarded for giving your computing time through bitcoin.In this way then, just as the values of traditional currencies were once linked to gold, the value of bitcoin can in a sense be seen as linked to electricity.The Geocities era of blockchainRemember the early days of the internet, when no one could have really predicted Facebook or cloud computing? That’s the time we’re in for bitcoin and blockchain. And if you consider that blockchain allows for the trading of all sorts of things, not just currency, the possibilities are almost endless.
Media giant 21st Century Fox, which was sold to Disney in December, rejected a higher buyout offer from Comcast over fears of regulatory risks © 2018 AFP The joint regulatory filing by Fox and Disney said a buyout by cable operator Comcast “carried a more significant risk of exposure to a range of negative outcomes for 21CF” while “a transaction with Disney would provide superior closing certainty as a result of the lower regulatory risk faced by Disney.”The decision came in the wake of the US Department of Justice legal challenge to a mega-merger between Time Warner and AT&T.Comcast also refused to provide compensation if the transaction was blocked by competition authorities, while Disney proposed $2.5 billion.Comcast had offered $34.40 per share compared to Disney’s $29.On December 14, Disney announced the purchase of many of Fox’s assets for $52.4 billion, though a final approval by antitrust authorities is not expected before 2019.Comcast was reported in February to have relaunched its bid, according to reports, offering to assuage some of Fox’s concerns.The media landscape is undergoing accelerated upheaval as traditional TV and film players seek to merge with cable operators to better combat tech giants, including Netflix and Amazon and their video streaming platforms. Explore further Media giant 21st Century Fox, which was sold to Disney in December, rejected a higher buyout offer from Comcast over fears of regulatory risks, a filing showed Wednesday. This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Citation: Fox rejected an offer from Comcast before Disney buyout: filing (2018, April 19) retrieved 18 July 2019 from https://phys.org/news/2018-04-fox-comcast-disney-buyout.html Comcast ponders new bid for 21st Century Fox: US media
© 2018 AFP Australia’s dominant telecommunications company Telstra Wednesday announced plans to axe 8,000 jobs—a quarter of its workforce—as part of a drastic new strategy to cope with an increasingly competitive industry. Telstra strikes $10B deal for Australia broadband Explore further Telstra employs 32,000 people across 20 countries, according to its most recent annual report telecommunications company Telstra reported a 36.6 percent jump in annual profit as it vowed to invest billions in boosting its network after customer frustrations over numerous outages. This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Citation: Australia telecom giant Telstra to axe 8,000 jobs (2018, June 20) retrieved 18 July 2019 from https://phys.org/news/2018-06-australian-telecom-giant-telstra-axe.html The decision by the company, one of Australia’s largest employers, is part of a shake-up targeting an extra Aus$1 billion (US$750 million) in cost-cutting by 2022, on top of Aus$1.5 billion previously announced.It will also split its mobile and infrastructure divisions into separate businesses.”In the future our workforce will be a smaller, knowledge-based one with a structure and way of working that is agile enough to deal with rapid change,” said chief executive Andrew Penn.”This means that some roles will no longer be required, some will change and there will also be new ones created.”The cuts come less than a month after Telstra said its 2017/18 earnings will likely be at the bottom of its guidance range of Aus$10.1 billion to Aus$10.6 billion, blaming increasing competition in mobile and fixed broadband.That warning sent its shares tumbling to a more-than six-year low of Aus$2.71. They had partially recovered since, but took another hit on Wednesday, closing 4.81 percent lower to Aus$2.77.CMC Markets chief market analyst Michael McCarthy said the restructuring plan may not be enough to please investors, who have watched Telstra’s share price almost halve in the past year.”Some investors think the Telstra patient needs radical surgery, and could view today’s measures as band-aids,” he said.Telstra employs 32,000 people across 20 countries, according to its most recent annual report. Of the jobs to go, one in four will be executive and middle management roles.Prime Minister Malcolm Turnbull called the announcement “heartbreaking” for the workers, but said he was confident most would find other jobs.”While one company reduces its workforce, there are other companies and new companies, including other telecommunication companies, creating new opportunities and jobs,” he said.Tipping pointPenn said the company had to take action to stay on top in a highly competitive market where technology was evolving quickly.”In this environment traditional companies that do not respond are most at risk. “We have worked hard preparing Telstra for this market dynamic while ensuring we did not act precipitously. However, we are now at a tipping point where we must act more boldly if we are to continue to be the nation’s leading telecommunications company.”Telstra has a range of businesses including fixed broadband, mobile, data and IP, network application services and digital media.Part of its new strategy will see it create a wholly-owned standalone infrastructure business unit from July 1.Called Telstra InfraCo, it will comprise the firm’s fixed-network infrastructure including data centres, non-mobiles related domestic fibre, international subsea cables, exchanges, poles, ducts and pipes. Its services will be sold to Telstra, wholesale customers and Australia’s National Broadband Network, controlling assets with a book value of about Aus$11 billion.”As technology innovation is increasingly relying on connectivity, the role of telecommunications infrastructure is becoming more important,” said Penn. “There is virtually no technological innovation happening today that does not rely on a high-quality, reliable, safe and secure telecommunications network. “In this world our infrastructure assets are becoming more valuable. By creating a new infrastructure-focused business unit we will better optimise and manage these assets.”Telstra also intends to “monetise assets of up to Aus$2 billion over the next two years to strengthen the balance sheet”, and has set aside Aus$600 million in restructuring costs.
Photos: See the World Through a Cat’s Eyes Meet the Rare and Fabulous Felines of ‘Super Cats’ (Photos) Australian officials are exploring multiple strategies for controlling populations of feral cats, including shooting, trapping and poisoning them with bait such as toxic sausages. Such culls are expected to eradicate around 2 million cats by 2020, but some species of vulnerable Australian wildlife may be running out of time, said study co-author Christopher Dickman, a professor in terrestrial ecology with the School of Life and Environmental Sciences at the University of Sydney. Cats are recognized as a threat to 35 species of birds, 36 mammal species, seven reptile species and three amphibian species, according to Australia’s Department of Sustainability, Environment, Water, Population and Communities (SEWPAC). “Many of Australia’s native species cannot withstand these high levels of predation and will become increasingly at risk of extinction unless the problem of cats in Australia is solved,” Dickman said in the statement. Originally published on Live Science.by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeVikings: Free Online GamePlay this for 1 min and see why everyone is addicted!Vikings: Free Online GameUndoBeverly Hills MDTop Plastic Surgeon Reveals: “You Can Fill In Wrinkles At Home” (Here’s How)Beverly Hills MDUndoSecurity SaversWindows Users Advised To Do This TodaySecurity SaversUndoTruthFinder People Search SubscriptionOne Thing All Liars Have in Common, Brace YourselfTruthFinder People Search SubscriptionUndoKelley Blue Book2019 Lexus Vehicles Worth Buying for Their Resale ValueKelley Blue BookUndoGundry MD Total Restore SupplementU.S. Cardiologist: It’s Like a Pressure Wash for Your InsidesGundry MD Total Restore SupplementUndo Here, Kitty, Kitty: 10 Facts for Cat Lovers A feral cat pauses for the camera after killing an Australian rosella parrot. Credit: Brisbane City Council When cats roam free, small wild animals die. And the body count in Australia exceeds 2 billion native animals per year. Environmental researchers in Australia compiled the alarming figure by combing through hundreds of studies on the predatory habits of Australia’s free-ranging pet cats as well as feral felines. The scientists documented cats’ historic and ongoing toll on Australian wildlife in the book “Cats in Australia” (CSIRO Publishing, 2019). In just one day, Australia’s millions of cats kill approximately 1.3 million birds, 1.8 million reptiles and over 3.1 million mammals. [In Photos: The Peskiest Alien Mammals]Headbutting Tiny Worms Are Really, Really LoudThis rapid strike produces a loud ‘pop’ comparable to those made by snapping shrimps, one of the most intense biological sounds measured at sea.Your Recommended PlaylistVolume 0%Press shift question mark to access a list of keyboard shortcutsKeyboard Shortcutsplay/pauseincrease volumedecrease volumeseek forwardsseek backwardstoggle captionstoggle fullscreenmute/unmuteseek to %SPACE↑↓→←cfm0-9接下来播放Why Is It ‘Snowing’ Salt in the Dead Sea?01:53 facebook twitter 发邮件 reddit 链接https://www.livescience.com/65915-australia-cats-wildlife-killers.html?jwsource=cl已复制直播00:0000:3500:35 Cats were introduced to Australia in the 18th century by European colonizers, and a report in 2017 found that feral cats could be found in 99.8% of the continent, including on 80% of Australia’s islands. Current estimates of the number of feral cats in Australia range from about 2 million to more than 6 million during years with a lot of rainfall, when prey is abundant. And every feral cat kills about 740 native animals annually, co-author Sarah Legge, a principal research fellow with the School of Earth and Environmental Sciences at Australia’s University of Queensland, said in a statement. There are also about 4 million pet cats in Australia. Pet owners who allow their cats to spend time outdoors may never witness their beloved animal’s killer instincts. Yet a single pet cat kills, on average, about 75 animals each year. That may not sound like much compared to the death toll racked up by feral cats. However, urban cat populations tend to be denser than in rural areas; with about 180 cats per square mile (60 per square kilometer) wildlife in urban areas pay a deadly price, Legge explained. “As a result, cats in urban areas kill many more animals per square kilometer each year than cats in the bush,” she said.
SHARE SHARE EMAIL politics BJP SHARE January 30, 2019 COMMENT COMMENTS Published on “Looks like they have learnt a lesson after trying to steal people’s mandate in Goa, Bihar, Manipur, Arunachal Pradesh, Uttarakhand and Karnataka. A day before the last session of the 16th Lok Sabha, Prime Minister Narendra Modi turned up the political temperature, recalling the virtues of electing a stable government, prompting Congress leader Ahmed Patel to ask if he (Modi) will sit in the Opposition if the BJP fails to secure the majority mark of 272 seats in the general elections.Addressing a gathering in Surat on Wednesday, Modi said the nation had suffered from the “disease” of instability under coalition governments for 30 years, before it elected a stable government with a full majority in 2014. Unstable governments were cobbled up as rag-tag formations. “Under a hung Parliament and coalition government, progress was hampered and the country even slipped backwards.”“But a stable government can take strong decisions. It is accountable and responsible. A coalition government shirks the responsibility, under the alibi that a coalition government cannot take decisions. In 2014, you elected a stable government with full majority. After four-and-a-half years, anyone can ask me about my government’s achievements.” He also recounted the virtue of demonetisation, saying it had wiped out black money from the real estate sector and made the poor and the middle class fulfil their dreams of buying their own houses. The previous governments had constructed only 25 lakh houses in decades, while the Modi government has constructed 1.30 crore houses for these people since 2014.In a series of tweets, Ahmed Patel, a Rajya Sabha MP from Gujarat, said: “If the Prime Minister thinks that coalition governments do not function properly, why doesn’t the BJP exit from the State governments of Maharashtra, Bihar and Goa?”“By saying that he can’t function in a coalition government, has the PM confirmed that if the BJP gets less than 272 seats, it will sit in (the) Opposition?” he said.“Looks like they have learnt a lesson after trying to steal people’s mandate in Goa, Bihar, Manipur, Arunachal Pradesh, Uttarakhand and Karnataka. ,” Patel tweeted.The PM flew to Surat and launched several development projects.
NEW DELHI: BJP national president Amit Shah on Tuesday appointed Swatantra Dev Singh as chief of party’s Uttar Pradesh unit. Singh, who is currently serving as minister of state with independent charge for transport and protocol in chief minister Yogi Adityanath-led government, was appointed at the post with immediate effect, said a BJP release undersigned by national general secretary Arun Singh. The BJP leader would take over charge from outgoing state chief and Union minister for skill development and entrepreneurship, Dr Mahendra Nath Pandey. “Congratulations and best wishes to Shri Swatantra Dev Singh for his appointment as the President of Uttar Pradesh BJP,” Adityanath tweeted. BJP had won 62 parliamentary seats out of 80 in the recently concluded general elections. Earlier in the day, Shah also appointed Chandrakant Patil as the president of BJP’s Maharashtra unit. Download The Times of India News App for Latest India News.XStart your day smart with stories curated specially for you